GSK Vaccines Global Regulatory Affairs (a team of 400+ people) presented their experiences with Binocs resource planning at the Making Pharmaceuticals conference that was held in Brussels on March 14th. Why did GSK GRA implement resource management? Why did GSK GRA choose for Binocs? And...

Business context  We are a global regulatory affairs department that submits 1000+ submissions/year. We need to make and support delivery commitments to regulatory authorities and our internal supply chain and production partners. It is an understatement when we say that this is challenging. Improvement potential  Before we implemented...

Binocs is used for capacity and operational planning in regulatory affairs and uses a RIM system (Regulatory Information Management) as a source of demand. It already integrates with Liquent from PAREXEL. In Q3 2018 we plan to have an operational integration with VEEVA Vault RIM. Binocs provides a machine...

Last week, April 27, TayganPoint and Bluecrux organized a round table discussion on Resource Management in Regulatory Affairs departments. RA experts from Merck (MSD), GlaxoSmthKline (GSK), Johnson & Johnson, Covance and Gens and Associates gathered around the topic that was introduced by Apostolos Mamakis and Pierre Roussel from GSK...